Table 3.
Hazard ratios of overall survival and cancer-specific survival in patients diagnosed with bladder cancer
| Overall Survival | Cancer-Specific Survival | |||||||
|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | |||
| Gender | ||||||||
| Male | 1.00 | 1.00 | ||||||
| Female (All patients) | 1.07 | 1.02 | 1.12 | 0.010 | 1.27 | 1.19 | 1.35 | <.001 |
| Female (Stage II) | 0.98 | 0.91 | 1.05 | 0.531 | 1.20 | 1.09 | 1.32 | <.001 |
| Female (Stage III) | 1.12 | 0.99 | 1.26 | 0.071 | 1.45 | 1.24 | 1.70 | <.001 |
| Female (Stage IV) | 1.19 | 1.08 | 1.30 | <.001 | 1.29 | 1.16 | 1.43 | <.001 |
Predictors in the model: treatment, year of diagnosis, age, race/ethnicity, marital status, rural area, census region, median income, tumor grade, stage, neoadjuvant chemotherapy, hydronephrosis and comorbidity score.